Directors Dealings
Director dealings are proprietary transactions by executives, which are reportable under Art. 19 MAR. The publication of these transactions is an important contribution to the prevention of insider dealing and market manipulation. In addition, knowledge of such transactions is of great importance to the market, as these transactions provide indications of management's assessment of the company's future business prospects. The information presented here relates to companies that are under the supervision of BaFin.
Heidelberg Pharma AG: A reportable insider transaction was published on 17th April 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 17th April 2024,
The Insider Transaction was made by Miller, Walter 
. The transaction toke place on 15th April 2024. The order was executed at the trading place Berlin Tradegate. . The aggregated volume was 6.050,00 EUR, based on an average price of 3,02 EUR. The nature of the Investment was Buy.
Heidelberg Pharma AG: A reportable insider transaction was published on 26th March 2024. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 26th March 2024,
The Insider Transaction was made by Baur, Dr. Georg F. . The transaction toke place on 25th March 2024. The order was executed at the trading place Frankfurt - Xetra. . The aggregated volume was 61.837,15 EUR, based on an average price of 3,09 EUR. The nature of the Investment was Buy.
Heidelberg Pharma AG: A reportable insider transaction was published on 18th December 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 18th December 2023,
The Insider Transaction was made by Pahl, Prof. Dr. Andreas . The transaction toke place on 15th December 2023. The order was executed at the trading place Xetra. . The aggregated volume was 10.130,00 EUR, based on an average price of 3,38 EUR. The nature of the Investment was Buy.
Heidelberg Pharma AG: A reportable insider transaction was published on 26th May 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 26th May 2023,
The Insider Transaction was made by Pahl, Prof. Dr. Andreas . The transaction toke place on 25th May 2023. The order was executed at the trading place Tradegate. . The aggregated volume was 10.000,00 EUR, based on an average price of 4,00 EUR. The nature of the Investment was Buy.
Heidelberg Pharma AG: A reportable insider transaction was published on 13th October 2022. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 13th October 2022,
The Insider Transaction was made by 4H invest GmbH . The transaction toke place on 11th October 2022. . The aggregated volume was 993.666,24 EUR, based on an average price of 6,44 EUR. The nature of the Investment was not specified.
Heidelberg Pharma AG: A reportable insider transaction was published on 13th October 2022. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 13th October 2022,
The Insider Transaction was made by Bohlini invest GmbH . The transaction toke place on 11th October 2022. . The aggregated volume was 964.061,56 EUR, based on an average price of 6,44 EUR. The nature of the Investment was not specified.
Heidelberg Pharma AG: A reportable insider transaction was published on 13th October 2022. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 13th October 2022,
The Insider Transaction was made by MH-LT-Investments GmbH . The transaction toke place on 11th October 2022. . The aggregated volume was 506.241,96 EUR, based on an average price of 6,44 EUR. The nature of the Investment was not specified.
Heidelberg Pharma AG: A reportable insider transaction was published on 6th September 2022. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 6th September 2022,
The Insider Transaction was made by Kudlek, Dr. Birgit . The transaction toke place on 2nd September 2022. . The aggregated volume was 7.496,16 EUR, based on an average price of 6,44 EUR. The nature of the Investment was not specified.
| Type | Total | Last | Made by | Go to |
|---|---|---|---|---|
| Equity Story | 81 | 27th March 2024 | EQS Group AG | EQS |
| Corporate Research | 0 | - | - | Corporate Research |
| Short Seller (DE) | 0 | - | - | SSR (DE) |
| Short Seller (UK) | 0 | - | - | SSR (UK) |
Disclaimer:
The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster.
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.
If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.